From SBA 7(a) loans to PE-backed recapitalizations, understand the capital stack options for acquiring a profitable medical weight loss practice in today's market.
Medical weight loss clinics generating $1M–$5M in revenue are among the most financeable healthcare businesses in the lower middle market. Cash-pay recurring revenue models, strong EBITDA margins, and SBA eligibility make these practices attractive to lenders. However, buyers must navigate lender sensitivity around GLP-1 prescribing compliance, provider key-person risk, and payer mix before securing optimal financing terms.
The most common financing vehicle for weight loss clinic acquisitions. Covers 80–90% of the purchase price with competitive rates, low equity requirements, and 10-year repayment terms suited to healthcare cash flows.
Pros
Cons
Seller carries a portion of the purchase price — typically 10–25% — structured as a subordinated note or earnout tied to patient retention rates and revenue milestones over 12–24 months post-close.
Pros
Cons
A PE-backed healthcare rollup acquires a majority stake (60–80%), with the selling physician retaining 20–40% equity to participate in platform upside through a future liquidity event.
Pros
Cons
$2,000,000 (represents a weight loss clinic at ~4.5x EBITDA on $445K adjusted EBITDA)
Purchase Price
~$17,500/month combined (SBA P&I at prime + 3% over 10 years plus seller note interest-only payments)
Monthly Service
Approximately 1.45x DSCR based on $445K EBITDA — above the 1.25x minimum threshold most SBA healthcare lenders require
DSCR
SBA 7(a) loan: $1,600,000 (80%) | Seller note tied to 12-month patient retention milestone: $200,000 (10%) | Buyer equity injection: $200,000 (10%)
Yes. Medical weight loss clinics with clean licensing histories, documented recurring revenue, and no passive income dependency are generally SBA-eligible. Cash-pay membership models are viewed favorably by most SBA healthcare lenders.
Lenders increasingly request documentation of GLP-1 prescribing protocols, telehealth compliance, and compounding pharmacy sourcing. Unresolved regulatory exposure or state board complaints can delay approval or require escrow holdbacks.
Most SBA lenders and PE platforms require minimum $300K–$500K in adjusted EBITDA. This ensures sufficient DSCR above 1.25x after normalizing for a market-rate medical director and post-close debt service obligations.
Yes, and it is common in weight loss clinic deals. Tie earnout milestones to specific patient retention rates or monthly recurring revenue thresholds — vague revenue targets frequently lead to post-close disputes between buyers and sellers.
More Weight Loss Clinic Guides
DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers